Purpose In multiple sclerosis (MS), the use of preference-based measures is limited to
generic measures such as Health Utilities Index Mark 2 and 3, the EQ-5D and the SF-6D …

Purpose Probabilistic mapping of the health status instrument SF-12 onto the health utility
instrument EuroQol—5 dimensions (EQ-5D)-3L using the UK-population-based scoring …

Background Multiple sclerosis imposes a heavy burden on the person who suffers from it
and on the relatives, due to the caregiving load involved. The objective was to analyse …

OBJECTIVES: To develop a patient-based, disease-specific measure of the health impact of
multiple sclerosis (MS) for use in clinical trials and clinical practice. DATA SOURCES …

Backround Guidelines for economic analyses of health care technologies require local input
data for reimbursement decisions in the countries of Central and Eastern Europe (CEE). The …

Introduction. Health state valuation is a key input in many economic evaluations that inform
resource allocation across competing healthcare interventions. Empirical evidence has …

This cost-of-illness analysis for the United Kingdom is part of a Europe-wide study on the
costs of multiple sclerosis (MS). The objective was to analyze the costs and quality of life …

Abstract Background: The SF-6D and EQ-5D are both preference-based measures of health.
Empirical work is required to determine what the smallest change is in utility scores that can …

Background Mapping of health-related quality-of-life measures to health utility values can
facilitate cost-utility evaluation. Regression-based methods tend to lead to shrinkage of …

Abstract Aims: To determine if EuroQoL 5-Dimension Health Questionnaire (EQ-5D) health
utility scores were able to discriminate among different levels of improvement in psoriasis …